Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
淋巴滤泡自然杀伤细胞清除 SIV 的机制
基本信息
- 批准号:10408913
- 负责人:
- 金额:$ 69.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdherenceAfricanAfrican Green MonkeyAnatomyAntiviral AgentsAutopsyB-LymphocytesBLR1 geneBloodCD4 Positive T LymphocytesCD8B1 geneCell physiologyCellsCercocebus atysChronicDNA MethylationDataDiseaseDisease ProgressionEarly MobilizationsEarly treatmentEpidemicEvolutionExhibitsFaceFailureFlow CytometryFrequenciesFutureGut MucosaHIVHIV-1HIV/SIV vaccineHumanImmunotherapeutic agentImpairmentInfectionInflammationInflammatoryInterleukin-15LeftLentivirus InfectionsLigandsLymphoid FollicleLymphoid TissueMacacaMacaca mulattaMediatingMedicineModelingMonkeysMorbidity - disease rateNatural Killer CellsNaturePathogenesisPathogenicityPatientsPeptidesPlasmaPopulationRNARegimenResearchRestRoleSIVSignal TransductionStainsT-Lymphocyte SubsetsTechniquesTestingTissuesVaccinesViralViral Load resultViral reservoirViremiaVirusVirus ReplicationWorkantiretroviral therapycell killingcostcytotoxiccytotoxic CD8 T cellsexhaustiongenome analysisimmune activationin vivoinnovationlongitudinal analysislymph nodesmemory CD4 T lymphocytenonhuman primatenovelnovel therapeuticspurgeresponsesecondary lymphoid organtraffickingtranscriptomicsviral RNA
项目摘要
Despite efficient suppression of plasma viremia in HIV-infected patients on cART, replication competent
virus is still recoverable from a variety of anatomic sites. A major reservoir of HIV and pathogenic SIV infection
in rhesus macaques (RM) are lymph node follicles (via replication in TFH cells and viral trapping by FDC) that
generally prohibit access to cytotoxic CD8+ T cells. Interestingly, nonpathogenic SIV infection of African green
monkeys (AGM) exhibits high viral loads in blood and the gut mucosae, but lacks virus in lymphoid follicles.
Natural killer (NK) cells provide rapid early responses to HIV/SIV infections and contribute substantially to
disease modulation and vaccine protection, but the underlying mechanisms for NK cell surveillance and
modulation of HIV/SIV reservoirs is unclear. Our recent research indicates that SIV can be effectively cleared
from lymphoid follicles in nonpathogenic AGM but not pathogenic RM hosts and is dependent on an IL-15-
dependent redistribution of NK cells to lymph node follicles and increased CXCR5 expression on AGM NK
(Huot et al. Nature Medicine 2017). In this innovative proposal we will utilize three SIV-infected nonhuman
primate models to test the central hypothesis that NK cells critically contribute to the reduction of SIV
reservoirs. Specifically we will: (1) Determine mechanisms associated with NK cell-mediated control of
SIV reservoirs; and (2) Determine mechanisms associated with NK cell failure to control SIV reservoirs
in lymph nodes and associated pathogenesis. Application of these data could contribute substantially to
future HIV/SIV vaccines, immunotherapeutics, or reservoir purging strategies that harness the potent antiviral
potential of NK cells.
尽管接受cART治疗的HIV感染患者的血浆病毒血症得到有效抑制,
病毒仍然可以从各种解剖部位恢复。艾滋病毒和致病性SIV感染的主要宿主
在恒河猴(RM)中,淋巴结滤泡(通过在TFH细胞中复制和FDC捕获病毒)
一般禁止接触细胞毒性CD 8 + T细胞。有趣的是,非洲绿色的非致病性SIV感染
猴(AGM)在血液和肠粘膜中表现出高病毒载量,但在淋巴滤泡中缺乏病毒。
自然杀伤(NK)细胞提供对HIV/SIV感染的快速早期反应,并在很大程度上有助于
疾病调节和疫苗保护,但NK细胞监测和
HIV/SIV储库的调节尚不清楚。我们最近的研究表明,SIV可以有效清除
来自非致病性AGM而非致病性RM宿主的淋巴滤泡,并依赖于IL-15-
NK细胞向淋巴结滤泡的依赖性再分布和AGM NK上CXCR 5表达增加
(Huot等人。Nature Medicine 2017)。在这个创新的建议中,我们将利用三个SIV感染的非人类
灵长类动物模型,以检验NK细胞对SIV减少起关键作用的中心假设
水库具体而言,我们将:(1)确定与NK细胞介导的控制相关的机制,
(2)确定与NK细胞不能控制SIV储库相关的机制
淋巴结中的淋巴结转移和相关的发病机制。这些数据的应用可以大大有助于
未来的HIV/SIV疫苗,免疫治疗剂或利用强效抗病毒药物的储库清除策略
NK细胞的潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger Keith Reeves其他文献
Roger Keith Reeves的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger Keith Reeves', 18)}}的其他基金
Microbial and innate immune mechanisms of oral inflammation during SIV infection
SIV感染期间口腔炎症的微生物和先天免疫机制
- 批准号:
10408915 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
NK 细胞动员作为 SARS-CoV-2 胃肠道疾病的致病病因
- 批准号:
10319735 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
NK 细胞动员作为 SARS-CoV-2 胃肠道疾病的致病病因
- 批准号:
10458737 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
淋巴滤泡自然杀伤细胞清除 SIV 的机制
- 批准号:
10305659 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
淋巴滤泡自然杀伤细胞清除 SIV 的机制
- 批准号:
10529270 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
NK 细胞动员作为 SARS-CoV-2 胃肠道疾病的致病病因
- 批准号:
10626025 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection
表达自然杀伤细胞受体的 B 细胞作为 SIV 感染粘膜免疫的调节剂
- 批准号:
10451069 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
针对 SIV 和 HIV 疫苗的抗原特异性 NK 细胞记忆
- 批准号:
10408910 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection
表达自然杀伤细胞受体的 B 细胞作为 SIV 感染粘膜免疫的调节剂
- 批准号:
9927204 - 财政年份:2019
- 资助金额:
$ 69.76万 - 项目类别:
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
针对 SIV 和 HIV 疫苗的抗原特异性 NK 细胞记忆
- 批准号:
9405715 - 财政年份:2017
- 资助金额:
$ 69.76万 - 项目类别:
相似海外基金
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 69.76万 - 项目类别:
Fellowship Programs
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
493049 - 财政年份:2023
- 资助金额:
$ 69.76万 - 项目类别:
Examining Social Determinants of Antiretroviral Adherence Trajectories among African American Adults with HIV
检查非洲裔美国成人艾滋病毒感染者抗逆转录病毒药物依从轨迹的社会决定因素
- 批准号:
10700611 - 财政年份:2023
- 资助金额:
$ 69.76万 - 项目类别:
MOVE Trial: MOtiVational Strategies to Empower African Americans to Improve Dialysis Adherence
MOVE 试验:激励非裔美国人提高透析依从性的策略
- 批准号:
10504154 - 财政年份:2022
- 资助金额:
$ 69.76万 - 项目类别:
MOVE Trial: MOtiVational Strategies to Empower African Americans to Improve Dialysis Adherence
MOVE 试验:激励非裔美国人提高透析依从性的策略
- 批准号:
10679005 - 财政年份:2022
- 资助金额:
$ 69.76万 - 项目类别:
Digital health for medication adherence among African Americans with hypertension
数字健康促进非裔美国人高血压患者的药物依从性
- 批准号:
10253402 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
PrEP adherence-concentration thresholds associated with HIV protection among African women
非洲妇女中与艾滋病毒保护相关的 PrEP 坚持浓度阈值
- 批准号:
10155163 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
Digital health for medication adherence among African Americans with hypertension
数字健康促进非裔美国人高血压患者的药物依从性
- 批准号:
10542998 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
MOVE: MOtiVational Strategies To Empower African Americans To Improve Dialysis Adherence
MOVE:激励非裔美国人提高透析依从性的策略
- 批准号:
10289587 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:
PrEP adherence-concentration thresholds associated with HIV protection among African women
非洲妇女中与艾滋病毒保护相关的 PrEP 坚持浓度阈值
- 批准号:
10560498 - 财政年份:2021
- 资助金额:
$ 69.76万 - 项目类别:














{{item.name}}会员




